Related Experiment Video
Updated: Aug 9, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Opportunistic fungal infections in immunocompromised hosts
1Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas.
Abstract:
Fungal infections in immunocompromised hosts cause major morbidity and mortality. The Candida and Aspergillus species are the most common causes, but many rarer organisms, once considered "contaminants," are being reported. The number of patients who receive immunosuppressive agents for the treatment of malignancy or for organ transplantation is increasing as well as the potential for local or disseminated fungal infections. The diagnosis of these infections is often difficult and the existing methods for treatment are often ineffective. A high degree of suspicion to identify fungal infections and to prompt initiation of treatment must be maintained if the survival rate of these patients is expected to improve.
Insights
Fungal infections pose significant risks for immunocompromised patients, with increasing incidence due to immunosuppressive therapies. Early diagnosis and prompt treatment are crucial for improving survival rates in these vulnerable individuals.
Area of Science:
- Medical Mycology
- Immunocompromised Host Research
- Infectious Diseases
Background:
- Immunocompromised patients face high risks of fungal infections, leading to severe illness and death.
- While Candida and Aspergillus are common, rarer fungal pathogens are increasingly recognized.
- Rising use of immunosuppressive agents for cancer and organ transplants expands the population at risk.
Purpose of the Study:
- To highlight the growing challenge of fungal infections in immunocompromised hosts.
- To emphasize the diagnostic difficulties and treatment limitations for these infections.
- To underscore the importance of clinical vigilance for early detection and intervention.
Main Methods:
- Review of current literature on fungal infections in immunocompromised populations.
- Analysis of trends in immunosuppressive therapy and associated fungal infections.
- Discussion of diagnostic challenges and therapeutic outcomes.
Main Results:
- Fungal infections contribute significantly to morbidity and mortality in immunocompromised patients.
- Rarer fungal species, previously dismissed as contaminants, are emerging as significant pathogens.
- Current diagnostic and treatment strategies often prove insufficient.
Conclusions:
- A high index of suspicion is essential for identifying fungal infections promptly.
- Early initiation of appropriate antifungal treatment is critical for patient survival.
- Further research into novel diagnostics and therapeutics is warranted.
More Related Videos
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis

